BIO president analyzes industry opportunities, challenges

05/6/2007 | Boston Globe (tiered subscription model), The

BIO's president says a Democratic Congress presents new possibilities for stem cell research funding but as a whole is less favorably inclined toward the biotechnology industry. James Greenwood, a former Republican congressman, says some of the top social issues currently facing the biotech industry are cost, access, stem cells and food products from cloned animals.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC